Photo of Sukrti Thonse

Associate, Corporate and Healthcare

Sukrti supports clients across a broad range of corporate and regulatory matters, advising at all stages of the business lifecycle with a strong concentration in healthcare and healthcare-adjacent industries. She regularly counsels physicians, medispas, multi-state provider groups, hospitals, and private equity sponsors on compliant corporate structuring, operational strategy, and growth initiatives. She provides guidance to healthcare start-ups, physician practices, and hospital systems on day-to-day operational, regulatory, and strategic matters, and assists clients in navigating complex and novel regulatory issues in highly regulated, multi-jurisdictional environments, including multi-state regulatory compliance and expansion.

In her corporate practice, Sukrti assists with the formation and capitalization of business structures and prepares key documents for fundraising, financing, and investor negotiations. She provides support on M&A transactions and in the structuring and implementation of Management Services Organization-Professional Corporation (MSO–PC) and Friendly PC models, ensuring compliance with Corporate Practice of Medicine (CPOM) doctrines, fee-splitting laws, and state ownership restrictions. Her work frequently involves advising on management services arrangements, equity structuring, rollover investments, and platform acquisitions involving physician-owned entities and private equity-backed healthcare companies.

Sukrti also has significant experience in physician and provider contracting, including drafting and negotiating employment agreements, independent contractor arrangements, professional services agreements, and compensation models (including wRVU-based structures), with careful attention to regulatory compliance and commercial reasonableness. Her practice includes coordinating regulatory due diligence and assisting with disclosure requirements, including for entities operating in FDA-regulated sectors.  She regularly structures and negotiates compensation arrangements with physicians in connection with employment and exclusive contracting arrangements, medical directorships, physician recruitment initiatives, office and equipment leases, and other key operational documents that support healthcare delivery and scalable platform growth.

She has developed particular strength in healthcare privacy and HIPAA compliance and works closely with firm partners to advise on federal and state regulatory frameworks. Sukrti regularly conducts multi-state regulatory analyses, including 50-state surveys addressing licensure, supervision, telehealth, reimbursement, and scope of practice considerations, enabling clients to expand across jurisdictions while mitigating regulatory risk.

Results may vary depending on your particular facts and legal circumstances.

Contact information:

sthonse@greenbaumlaw.com | 732.476.2480 | vCard

For more information visit the Greenbaum, Rowe, Smith & Davis LLP website.

When does a nonprofit healthcare provider qualify for complete charitable immunity – and when is it limited to New Jersey’s statutory damages cap? Our latest Client Alert examines Cassandra Gigi Smith v. Newark Community Health Centers, Inc. in which the New Jersey Supreme Court reversed the Appellate Division in an important decision for healthcare providers

People are increasingly turning to AI for answers and advice, but many don’t understand the significant risks that are involved, particularly in the healthcare sector.  Healthcare providers and healthcare-adjacent businesses who input patient information (PHI) into these tools may be violating HIPAA rules and risk regulatory scrutiny and audit exposure.  Our recent Client Alert examines

New legislation signed by New Jersey Governor Mikie Sherrill will now exempt certain qualified Advanced Practice Nurses (APNs) from longstanding joint protocol requirements, allowing them to practice independently. This Client Alert from our healthcare team provides an overview of the new law’s provisions, as well as related exceptions, compliance obligations, and key considerations for stakeholders.

One of the most immediate developments affecting hospitals is a new compliance requirement for off-campus hospital outpatient departments (OPDs) enacted through the FY2026 federal appropriations bill.

Beginning January 1, 2028, hospitals must obtain a unique National Provider Identifier (NPI) for each of its off-campus outpatient departments. Hospitals will also be required to attest that

Early federal enrollment data for the 2026 Affordable Care Act (ACA) marketplace plan year indicates a meaningful decline in coverage following the expiration of enhanced premium tax credits, which may have significant implications for hospitals and providers as coverage affordability pressures grow and payer mix volatility increases.

Enrollment Declines Following Subsidy Expiration

As of early

Implementation of the One Big Beautiful Bill Act (OBBBA) continues to reshape Medicaid financing structures across the country. In early 2026, the Centers for Medicare & Medicaid Services (CMS) issued several regulatory actions that operationalize key OBBBA provisions that affect how states fund Medicaid programs and how hospitals receive supplemental payments.

Two developments that are

The Rural Health Transformation (RHT) Program, created under the One Big Beautiful Bill Act (OBBBA), has moved from authorization to implementation with the distribution of the first $10 billion in federal funding for fiscal year 2026 (FY26). The RHT program represents a $50 billion, five-year federal initiative designed to strengthen rural healthcare infrastructure and expand

Since the enactment of the One Big Beautiful Bill Act (OBBBA) in mid-2025, the healthcare industry has been navigating a period of accelerated policy change affecting coverage, reimbursement, and care delivery. As the implementation of OBBBA-authorized funds continues, the data offers insights into how the law is reshaping the healthcare landscape at both the national

Medicare telehealth received a critical, if temporary, reprieve with the enactment of new legislation that extends key pandemic-era telehealth flexibilities that were set to expire on January 31, 2026, to December 31, 2027. In this Client Alert from our healthcare team, learn more about the impacts of the new law and why providers, health systems

New Jersey’s regulatory landscape may be frozen—but healthcare compliance risks are anything but. Governor Mikie Sherrill’s Executive Order 7 imposes a 90-day pause on new rulemaking, while former Governor Murphy’s termination of pandemic-era regulatory flexibilities is still set to take effect on February 16, 2026. For certain healthcare providers, these overlapping executive actions create uncertainty—but